Literature DB >> 33923885

A Detailed Analysis of Clinical Features and Outcomes of Patients with Pyogenic Spondylodiscitis Presenting without Axial Back Pain.

Luigi Aurelio Nasto1, Massimo Fantoni2, Valerio Cipolloni3, Luca Piccone3, Enrico Pola3,4, Alfredo Schiavone Panni4.   

Abstract

STUDY
DESIGN: Retrospective analysis of a single institution prospective, longitudinal database of spinal pyogenic infections. Diagnosis of pyogenic spondylodiscitis (PS) can be challenging. Although presenting symptoms are often non-specific, acute non-remitting axial back pain is the most striking feature. Nevertheless, several authors have reported on the uncommon occurrence of patients with PS without axial back pain. The aim of this study was to characterize presenting symptoms, causative agents, comorbidities, and treatment outcomes of patients presenting with painless pyogenic spondylodiscitis. A total of 214 patients diagnosed with PS were reviewed; patients were divided into two groups: patients presenting with no axial back pain (no pain group, n = 16), and patients presenting with axial back pain (control group, n = 198). Analyzed data comprised general demographics, presenting symptoms, comorbidities, spinal infection location, and amount of spinal involvement. While average age (62.4 vs. 65.0) and sex distribution was similar between the two groups, a significant diagnostic delay was noted in the control group (53 vs. 17 days, p < 0.001). Patients in the no pain group were more likely IV drug abusers or have had liver failure/cirrhosis. Anatomic distribution (i.e., cervical vs thoracolumbar) of the infection did not differ between the two groups, but a higher number of post-surgical infections was noted in the no pain group (37.5 vs. 15.6%, p = 0.026). E. coli and Pseudomonas spp. were more commonly seen in no pain group patients, and mortality was also higher in this group (12.5 vs. 6.0%, p = 0.004).

Entities:  

Keywords:  classifications of spinal infections; microbiology of spinal infections; pyogenic spondylodiscitis; spinal infections; surgical treatment of pyogenic spondylodiscitis

Year:  2021        PMID: 33923885     DOI: 10.3390/tropicalmed6020054

Source DB:  PubMed          Journal:  Trop Med Infect Dis        ISSN: 2414-6366


  18 in total

1.  Primary pyogenic infection of the spine in intravenous drug users: a prospective observational study.

Authors:  Zhi Wang; Brian Lenehan; Eyal Itshayek; Michael Boyd; Marcel Dvorak; Charles Fisher; Brian Kwon; Scott Paquette; John Street
Journal:  Spine (Phila Pa 1976)       Date:  2012-04-15       Impact factor: 3.468

2.  Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals.

Authors:  Martin C McHenry; Kirk A Easley; Geri A Locker
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

3.  Comparative study of postoperative and spontaneous pyogenic spondylodiscitis.

Authors:  Véronique Dufour; Antoine Feydy; Ludovic Rillardon; Aimée Redondo; Laurence Le Page; Frédéric Bert; Nadia Belmatoug; Bruno Fantin
Journal:  Semin Arthritis Rheum       Date:  2005-04       Impact factor: 5.532

4.  New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years.

Authors:  Enrico Pola; G Autore; V M Formica; V Pambianco; D Colangelo; R Cauda; M Fantoni
Journal:  Eur Spine J       Date:  2017-03-21       Impact factor: 3.134

Review 5.  Epidemiological and clinical features of pyogenic spondylodiscitis.

Authors:  M Fantoni; E M Trecarichi; B Rossi; V Mazzotta; G Di Giacomo; L A Nasto; E Di Meco; E Pola
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-04       Impact factor: 3.507

6.  Increasing incidence of pyogenic spondylodiscitis: a 14-year population-based study.

Authors:  Michala Kehrer; Court Pedersen; Thøger G Jensen; Annmarie T Lassen
Journal:  J Infect       Date:  2013-12-01       Impact factor: 6.072

Review 7.  2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults.

Authors:  Elie F Berbari; Souha S Kanj; Todd J Kowalski; Rabih O Darouiche; Andreas F Widmer; Steven K Schmitt; Edward F Hendershot; Paul D Holtom; Paul M Huddleston; Gregory W Petermann; Douglas R Osmon
Journal:  Clin Infect Dis       Date:  2015-07-29       Impact factor: 9.079

Review 8.  Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics.

Authors:  E Mylona; M Samarkos; E Kakalou; P Fanourgiakis; A Skoutelis
Journal:  Semin Arthritis Rheum       Date:  2008-06-11       Impact factor: 5.532

Review 9.  Outcome of conservative and surgical treatment of pyogenic spondylodiscitis: a systematic literature review.

Authors:  J P H J Rutges; D H Kempen; M van Dijk; F C Oner
Journal:  Eur Spine J       Date:  2015-11-19       Impact factor: 3.134

View more
  1 in total

1.  Pyogenic spinal infections in patients with chronic liver disease: illustrative case and systematic review.

Authors:  Gaston Camino-Willhuber; Ryan S Beyer; Matthew J Hatter; Austin J Franklin; Nolan J Brown; Sohaib Hashmi; Michael Oh; Nitin Bhatia; Yu-Po Lee
Journal:  J Neurosurg Case Lessons       Date:  2022-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.